POS0411 Characteristics at diagnosis associated to glucocorticoid use at 2 years for those with polymyalgia rheumatica - A national study of England

Yates, M., Saha, P., Aldus, C., Brown, J. and Macgregor, A. (2024) POS0411 Characteristics at diagnosis associated to glucocorticoid use at 2 years for those with polymyalgia rheumatica - A national study of England. In: UNSPECIFIED.

Full text not available from this repository. (Request a copy)

Abstract

Current guidelines recommend glucocorticoids (GCs) for the treatment of Polymyalgia Rheumatica (PMR) for 1 to 2 years. Surveys and administrative datasets from many European countries and the USA show that approximately 50% of patients are on GCs for at least 2 years. A previous study looking at individuals with PMR and GC dependence, found the neutrophil-lymphocyte ratio (NLR) at diagnosis to be associated with GC dependency.

Item Type:	Conference or Workshop Item (Paper)
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Centres > Population Health (former - to 2025) Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health Faculty of Medicine and Health Sciences > Research Groups > Musculoskeletal Medicine Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Centres > Public Health
Related URLs:	https://ard.bmj.com/lookup/doi/10.1136/a...
Depositing User:	LivePure Connector
Date Deposited:	18 Jul 2024 10:30
Last Modified:	30 Jul 2025 09:39
URI:	https://ueaeprints.uea.ac.uk/id/eprint/95946
DOI:	10.1136/annrheumdis-2024-eular.4165

Actions (login required)

View Item